Publicacions en què col·labora amb Juan José Granizo Martínez (45)

2019

  1. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality

    PLoS ONE, Vol. 14, Núm. 9

  2. Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 22-30

2018

  1. Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults

    Multidisciplinary Respiratory Medicine, Vol. 13, Núm. 1

2017

  1. Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp

    BMC Infectious Diseases, Vol. 17, Núm. 1

  2. Factores de riesgo para la colonización por enterobacterias productoras de carbapenemasas en el momento de admisión en una UCI quirúrgica: estudio retrospectivo

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 6, pp. 333-337

2016

  1. Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: A multicenter retrospective study

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, Núm. 1, pp. 32-39

2015

  1. Biomarkers (procalcitonin, C reactive protein, and lactate) as predictors of mortality in surgical patients with complicated intra-abdominal infection

    Surgical Infections, Vol. 16, Núm. 3, pp. 346-351

  2. Estudio observacional basado en la práctica clínica sobre la utilización de micafungina en Unidades de Cuidados Críticos Quirúrgicos

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 132-138

  3. Estudio observacional basado en la práctica diaria identificando factores asociados con la administración de dosis altas de tigeciclina en el tratamiento de la peritonitis secundaria en pacientes críticos

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 1, pp. 47-53

  4. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study

    Journal of Critical Care, Vol. 30, Núm. 3, pp. 537-542

  5. Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination

    Vaccine, Vol. 33, Núm. 42, pp. 5691-5699

2014

  1. Análisis de 38 casos de traqueobronquitis en pacientes inmunocompetentes con doble aislamiento de Aspergillus en muestras de tracto respiratorio inferior

    Revista Espanola de Quimioterapia, Vol. 27, Núm. 2, pp. 110-114

2012

  1. Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage

    Journal of Infection, Vol. 65, Núm. 5, pp. 447-452

  2. Comparative in vitro activity of common antibiotics and relationship with changes in Streptococcus pneumoniae serotypes causing otitis in children prior to and 10 years after introduction of conjugate vaccines in Spain

    International Journal of Antimicrobial Agents

  3. Correlation between clinical parameters characterising peri-implant and periodontal health: A practice-based research in Spain in a series of patients with implants installed 4-5 years ago

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 17, Núm. 5

  4. In vitro interference of tigecycline at subinhibitory concentrations on biofilm development by Enterococcus faecalis

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1155-1158

  5. Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: Colonisation or infection?

    BMC Infectious Diseases, Vol. 12

  6. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain

    International Journal of Antimicrobial Agents, Vol. 40, Núm. 1, pp. 18-23

2011

  1. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 5, pp. 2297-2302

  2. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009

    BMC Infectious Diseases, Vol. 11